GNTA Stock Analysis: Buy, Sell, or Hold?

GNTA - Genenta Science S.p.A. American Depositary Shares

Biological Products, (No Diagnostic Substances)
$1.79
-0.06 (-3.24%) ▼
5d: -2.72%
30d: +199.63%
90d: +138.57%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Mar 27, 2026 0d

Get Alerted When GNTA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: GNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: GNTA is currently trading at $1.79, which is considered slightly high relative to its 30-day fair value range of $0.77 to $1.96.

Technical Outlook: Technically, GNTA is showing sideways momentum. Immediate support is located at $0.57, while resistance sits at $2.58. Short-term momentum is weak, with the stock down 3.2% recently.

Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.98 (+277.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $0.77 - $1.96
Company Quality Score 53/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 56.3%

All Signals

  • NEUTRAL: Mixed technical signals (55/100)
  • BEARISH: Downward momentum (-3.2%)
  • BULLISH: Trading 277.3% below Wall St target ($6.98)

Trading Range Analysis

30-Day Trading Range $0.77 - $1.96
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $0.57
Resistance Level $2.58
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -3.49
Wall Street Target $6.98 (+277.3%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 25, 2026 10:16 AM ET
Data refreshes hourly during market hours. Next update: 11:16 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for GNTA.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$22 53 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 61 BUY
BNTX
BioNTech SE
STRONG BUY
21 analysts
$122 58 HOLD
DNTH
Dianthus Therapeutics In…
STRONG BUY
12 analysts
$128 61 BUY
DYN
Dyne Therapeutics Inc
STRONG BUY
14 analysts
$38 58 HOLD

More Analysis for GNTA

GNTA Technical Chart GNTA Price Prediction GNTA Earnings Date GNTA Investment Advisor GNTA Fair Price Analyzer GNTA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals